BK-JM-201: A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study in Parkinson#s Disease Patients With Dyskinesia to Assess the Efficacy and Safety/Tolerability of Fixed Dose Combinations of JM-010 and its Individual Components

Grants and Contracts Details

StatusFinished
Effective start/end date9/17/2012/2/21

Funding

  • Syneos Health LLC: $9,000.00